People
![Dr. Ilian Iliev](https://martletcap.com/wp-content/uploads/2024/07/ilian-iliev-1.png)
Dr. Ilian Iliev is the CEO of EMV Capital.
Prior to that he co-founded and was CEO of CambridgeIP Ltd (2006-2012), which he built into a leading IP and patent strategy and data analytics provider in the UK and internationally. Previously he co-founded a family business in industrials and electric engineering in Southern Africa. He is a Board member on behalf of the Group at many portfolio companies, including PDS Biotechnology Corporation., Glycotest Inc. (Chair), Sofant Technologies, PointGrab, Q-Bot, Martlet Capital, DName-iT, Vortex (Chair) and Wanda Health (Chair).
Ilian holds a PhD from Cambridge University’s Judge Business School with a focus on Venture Capital; Master’s in Economics from the Witwatersrand University, South Africa; and is a former Associate Fellow at Chatham House. He has authored numerous academic, policy and industry reports.